Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
September 26, 2018
Aimmune Therapeutics to Present at the Cantor Global Healthcare Conference on Wednesday, October 3
BRISBANE, Calif.--(BUSINESS WIRE)--Aimmune Therapeutics, Inc. (AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that President and CEO Jayson Dallas, M.D., will ...
September 26, 2018
Molecular Templates to Present at the Ladenburg Thalmann and Cantor Healthcare Conferences
AUSTIN, Texas, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (MTEM), a clinical-stage oncology company focused on the discovery and development of the company’s ...
September 26, 2018
AIT Therapeutics to Present at the Ladenburg 4th Annual Healthcare Conference
NEW YORK, Sept. 26, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide ...
September 26, 2018
Opiant Pharmaceuticals to Present at the Cantor Global Healthcare Conference
SANTA MONICA, Calif., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions and drug overdose, ...
September 26, 2018
Zosano Pharma Enters Into Capital Equipment Lease Agreement With Trinity Capital Investment
FREMONT, Calif., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (ZSAN) (“Zosano” or the “Company”), a clinical-stage biopharmaceutical company developing and commercializing therapies that deliver ...
September 26, 2018
Novus Therapeutics to Present at the Ladenburg Thalmann 2018 Healthcare Conference
IRVINE, Calif.--(BUSINESS WIRE)--Novus Therapeutics, Inc. (NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (“ENT”), ...
September 26, 2018
Kitov to Present Data on NT219 in Combination with Keytruda® and Erbitux® at AACR International Cancer Immunotherapy Conference
TEL AVIV, Israel, Sept. 26, 2018 (GLOBE NEWSWIRE) --  Kitov Pharma (NASDAQ/TASE: KTOV), an innovative biopharmaceutical company, today announced that Hadas Reuveni, Ph.D., Chief Technology ...
September 26, 2018
Genkyotex Announces First-Half 2018 Financial Results
Regulatory News:Genkyotex (Euronext Paris & Brussels: FR00011790542 – GKTX) (GKTX.PA) (GKTX.PA), a biopharmaceutical company and the leader in NOX therapies, announces its consolidated financial results ...
September 25, 2018
Celyad to Participate at Upcoming Healthcare Conferences
MONT-SAINT-GUIBERT, Belgium, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, and NASDAQ: CYAD), a clinical-stage biopharmaceutical company focused on the development of ...
September 25, 2018
Kamada to Present Corporate Overview at the Cantor Fitzgerald Global Healthcare Conference
REHOVOT, Israel, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ and TASE: KMDA), a plasma-derived protein therapeutics company, announced today that Amir London, Chief ...
September 25, 2018
Arcturus Therapeutics to Present at October Investor Conferences
SAN DIEGO, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (ARCT), a leading RNA medicines company, today announced that Joseph Payne will present at ...
September 25, 2018
BioTime to Participate on Industry Perspectives Roundtable at NEI Audacious Goals in Regenerative Medicine Workshop: Pathways for Retinal Cell Replacement Therapies
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that Francois Binette, Senior Vice President and BioTime’s ...
September 25, 2018
Reata Announces Positive Phase 2 Data for Bardoxolone Methyl in IgA Nephropathy and Type 1 Diabetic Chronic Kidney Disease
IRVING, Texas, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (RETA), a clinical-stage biopharmaceutical company, today announced positive, final results from the IgA nephropathy ...
September 25, 2018
Aptose to Present at Upcoming Investor Conferences in October 2018
SAN DIEGO, Calif. and TORONTO, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics ...
September 25, 2018
Arrowhead Pharmaceuticals to Present at Upcoming October 2018 Conferences
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (ARWR) today announced that it is scheduled to present at the following upcoming events: The 14th Annual Meeting of the ...
September 25, 2018
DURECT to Present at the Cantor Fitzgerald Global Healthcare Conference
CUPERTINO, Calif., Sept. 25, 2018 /PRNewswire/ -- DURECT Corporation (DRRX) announced today that James E. Brown, President and CEO, will be presenting at the Cantor Fitzgerald ...
September 25, 2018
Checkpoint Therapeutics Announces Presentation of Updated Data from Phase 1/2 Trial of EGFR Inhibitor CK-101
NEW YORK, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization ...
September 25, 2018
Eiger BioPharmaceuticals to Participate in Investor Conferences
PALO ALTO, Calif., Sept. 25, 2018 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of targeted therapies for rare and ultra-rare ...
September 25, 2018
UroGen Pharma to Present at the Ladenburg Thalmann 2018 Healthcare Conference
RA’ANANA, Israel & NEW YORK--(BUSINESS WIRE)--UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with ...
September 25, 2018
Krystal Biotech to Present at Upcoming Cantor Fitzgerald and Ladenburg Thalmann Conferences
PITTSBURGH, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech Inc., (“Krystal”) (KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients ...
Page 15 of 117